Trial Profile
An observational cohort study comparing effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2016 New trial record
- 17 Nov 2016 Results published in the European Journal of Cancer